TP53 and breast cancer: The primary objective of the present study has been to find if the copper phenolate complex [Cu(tdp)(phen)]+ would be cytotoxic to breast cancer cells of very different origins and which manifest in different forms, the p53-positive & ER-positive MCF-7 and p53-negative & ER-negative MDA-MB-231.